Watts Ryan J. — SEC Form 4 filings
SEC reporting owner CIK 1724310. 13 Form 4 filings on record with FilingPulse; latest filed 2026-08-14.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-01-09 to 2026-08-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 9 legs across 8 filings — 644,546 shares, $10,582,446 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: sale of 495,282 shares @ $15.00 ($7,429,230) in Denali Therapeutics Inc., filed 2025-07-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Denali Therapeutics Inc. (DNLI) | President and CEO, Director | 13 | — | 9 legs · 644,546 sh · $10,582,446 | 13 |
Form 4 filings — Watts Ryan J.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-14 | 4 | Denali Therapeutics Inc. (DNLI) | Gift (G): 32,220 @ $0 | EDGAR |
| 2026-01-08 | 4 | Denali Therapeutics Inc. (DNLI) | Sale (S): 35,198 @ $16.50 | EDGAR |
| 2026-01-05 | 4 | Denali Therapeutics Inc. (DNLI) | Grant/award (A): 78,960 @ $0 · Grant/award (A): 236,880 (derivative) @ $0 | EDGAR |
| 2025-09-05 | 4 | Denali Therapeutics Inc. (DNLI) | Gift (G): 50,000 @ $0 | EDGAR |
| 2025-07-11 | 4 | Denali Therapeutics Inc. (DNLI) | Option exercise (M): 455,282 @ $0.68 · Option exercise (M): 40,000 @ $5.28 · Sale (S): 495,282 @ $15 · Option exercise (M): 455,282 (derivative) @ $0 · Option exercise (M): 40,000 (derivative) @ $0 | EDGAR |
| 2025-01-08 | 4 | Denali Therapeutics Inc. (DNLI) | Sale (S): 29,266 @ $20.22 · Sale (S): 7,650 @ $20.81 | EDGAR |
| 2025-01-07 | 4 | Denali Therapeutics Inc. (DNLI) | Grant/award (A): 54,180 @ $0 · Grant/award (A): 162,540 (derivative) @ $0 | EDGAR |
| 2024-10-22 | 4 | Denali Therapeutics Inc. (DNLI) | Option exercise (M): 40,000 @ $0.68 · Sale (S): 40,000 @ $27.69 · Option exercise (M): 40,000 (derivative) @ $0 | EDGAR |
| 2024-08-22 | 4 | Denali Therapeutics Inc. (DNLI) | Sale (S): 2,260 @ $23.79 | EDGAR |
| 2024-03-29 | 4 | Denali Therapeutics Inc. (DNLI) | Gift (G): 40,000 @ $0 | EDGAR |
| 2024-02-15 | 4 | Denali Therapeutics Inc. (DNLI) | Sale (S): 9,589 @ $17.29 | EDGAR |
| 2024-01-11 | 4 | Denali Therapeutics Inc. (DNLI) | Sale (S): 7,818 @ $19.78 | EDGAR |
| 2024-01-09 | 4 | Denali Therapeutics Inc. (DNLI) | Sale (S): 17,483 @ $19.43 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1724310 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →